
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $5.3B | $5.6B | $5.8B | $6B | $6.4B | |
Revenue Growth (YoY) | 1.81% | 7.39% | 1.87% | 5.12% | 5.92% | |
Cost of Revenues | $1.6B | $1.6B | $1.7B | $1.7B | $1.8B | |
Gross Profit | $3.7B | $4B | $4.1B | $4.3B | $4.6B | |
Gross Profit Margin | 70.48% | 71.2% | 71.06% | 71.78% | 72.52% | |
R&D Expenses | $494.5M | $551.4M | $570.5M | $639.8M | $744.7M | |
Selling, General & Admin | $1.9B | $2B | $2B | $2.1B | $2.1B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $2.6B | $2.8B | $2.8B | $2.9B | $3.1B | |
Operating Income | $1.1B | $1.2B | $1.3B | $1.4B | $1.6B | |
Net Interest Expenses | $78.8M | $73.4M | $51.7M | $36.8M | $56.3M | |
EBT. Incl. Unusual Items | $1.1B | $1.1B | $1.3B | $1.4B | $1.5B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $246.7M | $237.8M | $262.6M | $314M | $323.6M | |
Net Income to Company | $823.4M | $861.4M | $1.1B | $1.1B | $1.2B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $823.4M | $861.4M | $1.1B | $1.1B | $1.2B | |
Basic EPS (Cont. Ops) | $3.11 | $3.30 | $4.25 | $4.45 | $4.91 | |
Diluted EPS (Cont. Ops) | $3.08 | $3.29 | $4.23 | $4.43 | $4.89 | |
Weighted Average Basic Share | $265M | $260.4M | $254.7M | $244.9M | $237.5M | |
Weighted Average Diluted Share | $266.6M | $261.8M | $255.8M | $246M | $238.4M | |
EBITDA | $1.6B | $1.7B | $1.9B | $2B | $2.1B | |
EBIT | $1.2B | $1.2B | $1.4B | $1.5B | $1.6B | |
Revenue (Reported) | $5.3B | $5.6B | $5.8B | $6B | $6.4B | |
Operating Income (Reported) | $1.1B | $1.2B | $1.3B | $1.4B | $1.6B | |
Operating Income (Adjusted) | $1.2B | $1.2B | $1.4B | $1.5B | $1.6B |
Period Ending | 2015-06-30 | 2016-06-30 | 2017-06-30 | 2018-06-30 | 2019-06-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $5.3B | $5.6B | $5.7B | $6.1B | $6.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.6B | $1.6B | $1.6B | $1.7B | $1.7B | |
Gross Profit | $3.7B | $4B | $4B | $4.3B | $4.6B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.9B | $2B | $2B | $2.1B | $2.1B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $2.6B | $2.8B | $2.7B | $2.9B | $3B | |
Operating Income | $1.1B | $1.2B | $1.3B | $1.4B | $1.6B | |
Net Interest Expenses | $80.5M | $73.6M | $51.9M | $36.8M | $55.7M | |
EBT. Incl. Unusual Items | $1.1B | $1.1B | $1.3B | $1.4B | $1.5B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $247.3M | $237M | $260.7M | $314.2M | $320.4M | |
Net Income to Company | $825.6M | $854.7M | $1.1B | $1.1B | $1.2B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $825.6M | $854.7M | $1.1B | $1.1B | $1.2B | |
Basic EPS (Cont. Ops) | $3.12 | $3.28 | $4.20 | $4.45 | $4.86 | |
Diluted EPS (Cont. Ops) | $3.09 | $3.26 | $4.18 | $4.43 | $4.84 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.6B | $1.7B | $1.9B | $2B | $2.1B | |
EBIT | $1.2B | $1.2B | $1.4B | $1.5B | $1.6B | |
Revenue (Reported) | $5.3B | $5.6B | $5.7B | $6.1B | $6.3B | |
Operating Income (Reported) | $1.1B | $1.2B | $1.3B | $1.4B | $1.6B | |
Operating Income (Adjusted) | $1.2B | $1.2B | $1.4B | $1.5B | $1.6B |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $889.3M | $1.1B | $1.4B | $1.3B | $992.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.2B | $1.1B | $1.2B | $1.2B | $1.2B | |
Inventory | $83.6M | $73.6M | $84.7M | $92.9M | $82.2M | |
Prepaid Expenses | $287.8M | $375.9M | $227.3M | $190.1M | $233.1M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $2.7B | $3.1B | $3.2B | $3B | $2.8B | |
Property Plant And Equipment | $495.7M | $425.7M | $388.2M | $353.7M | $304.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $4.9B | $4.7B | $4.7B | $4.8B | $4.9B | |
Other Intangibles | $2.1B | $1.8B | $1.8B | $1.8B | $1.8B | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $10.3B | $10.2B | $10.2B | $10.1B | $9.9B | |
Accounts Payable | $163.6M | $139.3M | $157.6M | $182.4M | $165.5M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $88.6M | $80.4M | $74M | $69.6M | $65.6M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $3.9B | $3.5B | $4.1B | $4.2B | $3.9B | |
Long-Term Debt | $2.8B | $3.2B | $2.8B | $3.2B | $3.6B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $7.7B | $7.5B | $7.7B | $8.1B | $8.3B | |
Common Stock | $39.4M | $36.2M | $33.2M | $33.2M | $30.2M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $2.6B | $2.7B | $2.5B | $1.9B | $1.6B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2.6B | $2.7B | $2.5B | $1.9B | $1.6B | |
Total Liabilities and Equity | $10.3B | $10.2B | $10.2B | $10.1B | $9.9B | |
Cash and Short Terms | $889.3M | $1.1B | $1.4B | $1.3B | $992.7M | |
Total Debt | $3.4B | $3.2B | $3.5B | $3.8B | $4B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $889.3M | $1.1B | $1.4B | $1.3B | $992.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.2B | $1.1B | $1.2B | $1.2B | $1.2B | |
Inventory | $83.6M | $73.6M | $84.7M | $92.9M | $82.2M | |
Prepaid Expenses | $287.8M | $375.9M | $227.3M | $190.1M | $233.1M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $2.7B | $3.1B | $3.2B | $3B | $2.8B | |
Property Plant And Equipment | $495.7M | $425.7M | $388.2M | $353.7M | $304.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $4.9B | $4.7B | $4.7B | $4.8B | $4.9B | |
Other Intangibles | $2.1B | $1.8B | $1.8B | $1.8B | $1.8B | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $10.3B | $10.2B | $10.2B | $10.1B | $9.9B | |
Accounts Payable | $163.6M | $139.3M | $157.6M | $182.4M | $165.5M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $88.6M | $80.4M | $74M | $69.6M | $65.6M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $3.9B | $3.5B | $4.1B | $4.2B | $3.9B | |
Long-Term Debt | $2.8B | $3.2B | $2.8B | $3.2B | $3.6B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $7.7B | $7.5B | $7.7B | $8.1B | $8.3B | |
Common Stock | $39.4M | $36.2M | $33.2M | $33.2M | $30.2M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2.6B | $2.7B | $2.5B | $1.9B | $1.6B | |
Total Liabilities and Equity | $10.3B | $10.2B | $10.2B | $10.1B | $9.9B | |
Cash and Short Terms | $889.3M | $1.1B | $1.4B | $1.3B | $992.7M | |
Total Debt | $3.4B | $3.2B | $3.5B | $3.8B | $4B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $823.4M | $861.4M | $1.1B | $1.1B | $1.2B | |
Depreciation & Amoritzation | $483.1M | $498.1M | $455.6M | $476.3M | $491.4M | |
Stock-Based Compensation | $27.4M | $28.4M | $29.5M | $33.6M | $33.6M | |
Change in Accounts Receivable | $18.3M | -$111.2M | $96M | $4.3M | -$34.6M | |
Change in Inventories | -- | -$3.5M | -$11.6M | -$7.6M | $9.7M | |
Cash From Operations | $1.4B | $1.5B | $1.7B | $1.7B | $1.8B | |
Capital Expenditures | $271.8M | $284M | $311.1M | $350.8M | $339.9M | |
Cash Acquisitions | -$394M | -$37.9M | $14.8M | -$57.4M | -$361.5M | |
Cash From Investing | -$643M | -$339.6M | -$315.3M | -$404.9M | -$705.7M | |
Dividends Paid (Ex Special Dividend) | -$381.4M | -$441.3M | -$447.1M | -$505.6M | -$563.9M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $566.4M | $591.6M | $665.4M | $1.1B | $1.3B | |
Long-Term Debt Repaid | -$414.6M | -$118.3M | -$132.9M | -$1B | -$798.8M | |
Repurchase of Common Stock | -$399.7M | -$485.1M | -$1.1B | -$1.1B | -$1.1B | |
Other Financing Activities | -$2.3M | -- | -- | -- | -$2.2M | |
Cash From Financing | -$716.1M | -$533.6M | -$1B | -$1.6B | -$1.2B | |
Beginning Cash (CF) | $495.6M | $430.7M | $1B | $1.4B | $1.1B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $8M | $655.5M | $307.9M | -$335.6M | -$90.9M | |
Ending Cash (CF) | $825.7M | $1.2B | $1.4B | $1.2B | $1B | |
Levered Free Cash Flow | $1.1B | $1.2B | $1.4B | $1.3B | $1.5B |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $825.6M | $854.7M | $1.1B | $1.1B | $1.2B | |
Depreciation & Amoritzation | $484.9M | $493.6M | $451.6M | $476.8M | $486.4M | |
Stock-Based Compensation | $27.6M | $28.1M | $29.1M | $33.6M | $33.2M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.4B | $1.5B | $1.6B | $1.7B | $1.8B | |
Capital Expenditures | $272.8M | $281.1M | $307.6M | $351M | $336.3M | |
Cash Acquisitions | -$411M | -$42.4M | $11.3M | -$57.7M | -$356M | |
Cash From Investing | -$660M | -$340.7M | -$314.6M | -$405.5M | -$696.6M | |
Dividends Paid (Ex Special Dividend) | -$379.1M | -$440.9M | -$444.8M | -$506.3M | -$558.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $581.8M | $604.1M | $649.5M | $1.1B | $1.3B | |
Long-Term Debt Repaid | -- | -$114.4M | -$128.9M | -$1B | -$793.5M | |
Repurchase of Common Stock | -$403.3M | -$481.3M | -$1B | -$1.1B | -$1.1B | |
Other Financing Activities | -$2.5M | -- | -- | -- | -$2.2M | |
Cash From Financing | -$720.9M | -$512.3M | -$1B | -$1.6B | -$1.2B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$222.5M | $621.2M | $205.7M | -$232.5M | -$106.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $1.1B | $1.2B | $1.3B | $1.3B | $1.4B |
Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.